Rezon Bio provides integrated analytical development services designed to support biosimilar comparative assessments programs from early characterization through to regulatory submission. Our analytical team covers structural and functional characterization, physicochemical testing, immunogenicity assessment, stability studies, and method development, optimization, and validation, forced degradation, comparability studies in accordance with FDA, EMA, and ICH guidelines. For biosimilar programs, robust similarity packages are a regulatory and commercial necessity, and our team has built and submitted these packages multiple times in the context of commercial biosimilar development. Analytical services are co-located with our process development and GMP manufacturing capabilities, ensuring continuity of data and consistency of methods across every stage of the program. Our analytical capabilities are also available as standalone services.
Article
